by Healthbanks | Sep 14, 2020 | Latst News
Welcome to HealthBanks The HealthBanks network was created in response to the rapidly growing stem cell and gene therapy fields. Advancements being made in these fields are transforming the face of modern medicine, providing hope to families and helping give those...
by Healthbanks | Mar 23, 2020 | Immune Cell Banking News, Latst News
RANCHO CORDOVA, Calif., Jan. 3, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that ImmuneCyte Life Sciences, Inc. (“ImmuneCyte”), an 80/20 joint...
by Healthbanks | Dec 16, 2019 | Latst News
RANCHO CORDOVA, Calif., Nov. 26, 2019 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the company has closed on its joint venture agreement with...
by Healthbanks | Aug 15, 2019 | Immune Cell Banking News
From medpagetoday.com CHICAGO — Two different chimeric antigen receptor (CAR) T-cell therapies showed activity in solid tumors, according to preliminary trial data reported here. Mesothelin-targeted CAR T cells, combined with a PD-1 inhibitor, led to complete...
by Healthbanks | Aug 15, 2019 | Immune Cell Banking News, Latst News
From dailymemphian.com About a year ago, Bradford Neveu started experiencing night sweats and an elevated heart rate. “Then it got to the point where my chest would hurt and I’d get about halfway through the workday and I’d just be in so much pain and distress I knew...
